Trial · NCT00093496
Adverse events41
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 41
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hemoglobin decreased | Blood and lymphatic system disorders | All Patients Receiving Gemcitabine | 24 | 29 | 79 |
| other | Abdominal pain | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 3 | 29 | 6 |
| other | Constipation | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 3 | 29 | 8 |
| other | Diarrhea | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 9 | 29 | 15 |
| other | Flatulence | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 1 | 29 | 1 |
| other | Gastric ulcer | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 1 | 29 | 1 |
| other | Nausea | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 16 | 29 | 26 |
| other | Stomach pain | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 1 | 29 | 3 |
| other | Vomiting | Gastrointestinal disorders | All Patients Receiving Gemcitabine | 10 | 29 | 13 |
| other | Edema limbs | General disorders | All Patients Receiving Gemcitabine | 1 | 29 | 3 |
| other | Fatigue | General disorders | All Patients Receiving Gemcitabine | 7 | 29 | 19 |
| other | Dermatitis radiation | Injury, poisoning and procedural complications | All Patients Receiving Gemcitabine | 1 | 29 | 1 |
| other | Alkaline phosphatase increased | Investigations | All Patients Receiving Gemcitabine | 6 | 29 | 9 |
| other | Aspartate aminotransferase increased | Investigations | All Patients Receiving Gemcitabine | 8 | 29 | 12 |
| other | Leukocyte count decreased | Investigations | All Patients Receiving Gemcitabine | 14 | 29 | 29 |
| other | Neutrophil count decreased | Investigations | All Patients Receiving Gemcitabine | 17 | 29 | 33 |
| other | Platelet count decreased | Investigations | All Patients Receiving Gemcitabine | 9 | 29 | 22 |
| other | Anorexia | Metabolism and nutrition disorders | All Patients Receiving Gemcitabine | 4 | 29 | 9 |
| other | Dizziness | Nervous system disorders | All Patients Receiving Gemcitabine | 2 | 29 | 2 |
| other | Peripheral motor neuropathy | Nervous system disorders | All Patients Receiving Gemcitabine | 1 | 29 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00093496/events